Loading…
Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects
The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in HIV‐infected subjects receiving indinavir. Fourteen HIV‐infected subjects took 800 mg of indinavir with 6 ounces (180 ml) of water or double‐strengt...
Saved in:
Published in: | Journal of clinical pharmacology 2001-04, Vol.41 (4), p.435-442 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723 |
---|---|
cites | cdi_FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723 |
container_end_page | 442 |
container_issue | 4 |
container_start_page | 435 |
container_title | Journal of clinical pharmacology |
container_volume | 41 |
creator | Shelton, Mark J. Wynn, Heather E. Hewitt, Ross G. DiFrancesco, Robin |
description | The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in HIV‐infected subjects receiving indinavir. Fourteen HIV‐infected subjects took 800 mg of indinavir with 6 ounces (180 ml) of water or double‐strength grapefruit juice. Gastric pH was measured and blood samples were collected for 5 hours after indinavir dosing. Grapefruit juice increased the mean gastric pH (from 1.39 ± 0.4 to 3.20 ± 0.3; p < 0.05) and slightly delayed the absorption of indinavir (tmax increased from 1.12 ± 0.8hto 1.56± 0.6 h; p < 0.05). However, there were no significant differences in indinavir exposure. Cmax was 16.7 ± 7.3 μ with water versus 13.9 ± 4.2 μ with grapefruit juice (p = NS), and AUC0–8 was 37.5 ± 19 with water versus 36.9 ± 15 with grapefruit juice (p = NS). The authors concluded that concomitant administration of grapefruit juice increases gastric pH and delays indinavir absorption but does not uniformly affect the systemic bioavailability of indinavir in HIV‐infected subjects. |
doi_str_mv | 10.1177/00912700122010140 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_235857940</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75107604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723</originalsourceid><addsrcrecordid>eNqFkEuP0zAURi0EYsrAD2CDLFhnuH4kjpeoKn2oGooYmBWyHNdR3aZxx07m8e9x1GhYsGBlWz7nflcfQu8JXBEixGcASagAIJQCAcLhBZqQPKcZL4C_RJPhPxuAC_Qmxn0CC56T1-iCEAZcAkzQ71ldW9NF7Gs8D_pk69C7Dq96Zyz2Ld7sdDhq4w-utZ0zePZ48rEPFnceL9uta_W9C9i1eLH8lW18dJ27t_hHX-2HqW_Rq1o30b4bz0v08-vsZrrI1t_my-mXdWZySSAjWuRFSSrGaFGAKUtRy62seG04l6Wm0titsFsiSCkYFLqSQoLNTUFLqo2g7BJ9PM89BX_X29ipve9DmyIVZXmZC8khQeQMmeBjDLZWp-COOjwpAmroU_3TZ3I-jIP76mi3f42xwAR8GgEdjW7qoFvj4jMnWZkqTxQ_Uw--6WyIh6Z_sEHtrG66XYoF4Ck2oykaeHplMNySVoyaa-zT_9dVq-lmwdnQR3YWXezs47Oow0EVgolc3V7P1YLKG7m6_a7W7A9-mahq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235857940</pqid></control><display><type>article</type><title>Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects</title><source>Wiley</source><creator>Shelton, Mark J. ; Wynn, Heather E. ; Hewitt, Ross G. ; DiFrancesco, Robin</creator><creatorcontrib>Shelton, Mark J. ; Wynn, Heather E. ; Hewitt, Ross G. ; DiFrancesco, Robin</creatorcontrib><description>The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in HIV‐infected subjects receiving indinavir. Fourteen HIV‐infected subjects took 800 mg of indinavir with 6 ounces (180 ml) of water or double‐strength grapefruit juice. Gastric pH was measured and blood samples were collected for 5 hours after indinavir dosing. Grapefruit juice increased the mean gastric pH (from 1.39 ± 0.4 to 3.20 ± 0.3; p < 0.05) and slightly delayed the absorption of indinavir (tmax increased from 1.12 ± 0.8hto 1.56± 0.6 h; p < 0.05). However, there were no significant differences in indinavir exposure. Cmax was 16.7 ± 7.3 μ with water versus 13.9 ± 4.2 μ with grapefruit juice (p = NS), and AUC0–8 was 37.5 ± 19 with water versus 36.9 ± 15 with grapefruit juice (p = NS). The authors concluded that concomitant administration of grapefruit juice increases gastric pH and delays indinavir absorption but does not uniformly affect the systemic bioavailability of indinavir in HIV‐infected subjects.</description><identifier>ISSN: 0091-2700</identifier><identifier>EISSN: 1552-4604</identifier><identifier>DOI: 10.1177/00912700122010140</identifier><identifier>PMID: 11304900</identifier><identifier>CODEN: JCPCBR</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Beverages ; Biological and medical sciences ; Biological Availability ; Chromatography, High Pressure Liquid ; Citrus ; Cross-Over Studies ; Female ; Food-Drug Interactions ; Gastric Juice - metabolism ; Half-Life ; HIV Infections - drug therapy ; HIV Infections - metabolism ; Humans ; Hydrogen-Ion Concentration ; Indinavir - pharmacokinetics ; Indinavir - pharmacology ; Male ; Medical sciences ; Middle Aged ; Models, Biological ; Pharmacology. Drug treatments ; Time Factors</subject><ispartof>Journal of clinical pharmacology, 2001-04, Vol.41 (4), p.435-442</ispartof><rights>2001 American College of Clinical Pharmacology</rights><rights>2001 SAGE Publications</rights><rights>2001 INIST-CNRS</rights><rights>Copyright SAGE PUBLICATIONS, INC. Apr 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723</citedby><cites>FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=938645$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11304900$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shelton, Mark J.</creatorcontrib><creatorcontrib>Wynn, Heather E.</creatorcontrib><creatorcontrib>Hewitt, Ross G.</creatorcontrib><creatorcontrib>DiFrancesco, Robin</creatorcontrib><title>Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects</title><title>Journal of clinical pharmacology</title><addtitle>J Clin Pharmacol</addtitle><description>The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in HIV‐infected subjects receiving indinavir. Fourteen HIV‐infected subjects took 800 mg of indinavir with 6 ounces (180 ml) of water or double‐strength grapefruit juice. Gastric pH was measured and blood samples were collected for 5 hours after indinavir dosing. Grapefruit juice increased the mean gastric pH (from 1.39 ± 0.4 to 3.20 ± 0.3; p < 0.05) and slightly delayed the absorption of indinavir (tmax increased from 1.12 ± 0.8hto 1.56± 0.6 h; p < 0.05). However, there were no significant differences in indinavir exposure. Cmax was 16.7 ± 7.3 μ with water versus 13.9 ± 4.2 μ with grapefruit juice (p = NS), and AUC0–8 was 37.5 ± 19 with water versus 36.9 ± 15 with grapefruit juice (p = NS). The authors concluded that concomitant administration of grapefruit juice increases gastric pH and delays indinavir absorption but does not uniformly affect the systemic bioavailability of indinavir in HIV‐infected subjects.</description><subject>Adult</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Beverages</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Citrus</subject><subject>Cross-Over Studies</subject><subject>Female</subject><subject>Food-Drug Interactions</subject><subject>Gastric Juice - metabolism</subject><subject>Half-Life</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Indinavir - pharmacokinetics</subject><subject>Indinavir - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><issn>0091-2700</issn><issn>1552-4604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkEuP0zAURi0EYsrAD2CDLFhnuH4kjpeoKn2oGooYmBWyHNdR3aZxx07m8e9x1GhYsGBlWz7nflcfQu8JXBEixGcASagAIJQCAcLhBZqQPKcZL4C_RJPhPxuAC_Qmxn0CC56T1-iCEAZcAkzQ71ldW9NF7Gs8D_pk69C7Dq96Zyz2Ld7sdDhq4w-utZ0zePZ48rEPFnceL9uta_W9C9i1eLH8lW18dJ27t_hHX-2HqW_Rq1o30b4bz0v08-vsZrrI1t_my-mXdWZySSAjWuRFSSrGaFGAKUtRy62seG04l6Wm0titsFsiSCkYFLqSQoLNTUFLqo2g7BJ9PM89BX_X29ipve9DmyIVZXmZC8khQeQMmeBjDLZWp-COOjwpAmroU_3TZ3I-jIP76mi3f42xwAR8GgEdjW7qoFvj4jMnWZkqTxQ_Uw--6WyIh6Z_sEHtrG66XYoF4Ck2oykaeHplMNySVoyaa-zT_9dVq-lmwdnQR3YWXezs47Oow0EVgolc3V7P1YLKG7m6_a7W7A9-mahq</recordid><startdate>200104</startdate><enddate>200104</enddate><creator>Shelton, Mark J.</creator><creator>Wynn, Heather E.</creator><creator>Hewitt, Ross G.</creator><creator>DiFrancesco, Robin</creator><general>Blackwell Publishing Ltd</general><general>SAGE Publications</general><general>Sage Science</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>200104</creationdate><title>Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects</title><author>Shelton, Mark J. ; Wynn, Heather E. ; Hewitt, Ross G. ; DiFrancesco, Robin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Beverages</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Citrus</topic><topic>Cross-Over Studies</topic><topic>Female</topic><topic>Food-Drug Interactions</topic><topic>Gastric Juice - metabolism</topic><topic>Half-Life</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Indinavir - pharmacokinetics</topic><topic>Indinavir - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shelton, Mark J.</creatorcontrib><creatorcontrib>Wynn, Heather E.</creatorcontrib><creatorcontrib>Hewitt, Ross G.</creatorcontrib><creatorcontrib>DiFrancesco, Robin</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shelton, Mark J.</au><au>Wynn, Heather E.</au><au>Hewitt, Ross G.</au><au>DiFrancesco, Robin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects</atitle><jtitle>Journal of clinical pharmacology</jtitle><addtitle>J Clin Pharmacol</addtitle><date>2001-04</date><risdate>2001</risdate><volume>41</volume><issue>4</issue><spage>435</spage><epage>442</epage><pages>435-442</pages><issn>0091-2700</issn><eissn>1552-4604</eissn><coden>JCPCBR</coden><abstract>The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in HIV‐infected subjects receiving indinavir. Fourteen HIV‐infected subjects took 800 mg of indinavir with 6 ounces (180 ml) of water or double‐strength grapefruit juice. Gastric pH was measured and blood samples were collected for 5 hours after indinavir dosing. Grapefruit juice increased the mean gastric pH (from 1.39 ± 0.4 to 3.20 ± 0.3; p < 0.05) and slightly delayed the absorption of indinavir (tmax increased from 1.12 ± 0.8hto 1.56± 0.6 h; p < 0.05). However, there were no significant differences in indinavir exposure. Cmax was 16.7 ± 7.3 μ with water versus 13.9 ± 4.2 μ with grapefruit juice (p = NS), and AUC0–8 was 37.5 ± 19 with water versus 36.9 ± 15 with grapefruit juice (p = NS). The authors concluded that concomitant administration of grapefruit juice increases gastric pH and delays indinavir absorption but does not uniformly affect the systemic bioavailability of indinavir in HIV‐infected subjects.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>11304900</pmid><doi>10.1177/00912700122010140</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-2700 |
ispartof | Journal of clinical pharmacology, 2001-04, Vol.41 (4), p.435-442 |
issn | 0091-2700 1552-4604 |
language | eng |
recordid | cdi_proquest_journals_235857940 |
source | Wiley |
subjects | Adult Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Beverages Biological and medical sciences Biological Availability Chromatography, High Pressure Liquid Citrus Cross-Over Studies Female Food-Drug Interactions Gastric Juice - metabolism Half-Life HIV Infections - drug therapy HIV Infections - metabolism Humans Hydrogen-Ion Concentration Indinavir - pharmacokinetics Indinavir - pharmacology Male Medical sciences Middle Aged Models, Biological Pharmacology. Drug treatments Time Factors |
title | Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T15%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Grapefruit%20Juice%20on%20Pharmacokinetic%20Exposure%20to%20Indinavir%20in%20HIV-Positive%20Subjects&rft.jtitle=Journal%20of%20clinical%20pharmacology&rft.au=Shelton,%20Mark%20J.&rft.date=2001-04&rft.volume=41&rft.issue=4&rft.spage=435&rft.epage=442&rft.pages=435-442&rft.issn=0091-2700&rft.eissn=1552-4604&rft.coden=JCPCBR&rft_id=info:doi/10.1177/00912700122010140&rft_dat=%3Cproquest_cross%3E75107604%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5910-1a75681b332660c887f9d9b4fc4498a29ced7ed17187306ab9790e5c6282ac723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=235857940&rft_id=info:pmid/11304900&rfr_iscdi=true |